GeoVax Labs, Inc. (GOVX)

GeoVax Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	6.45	27.61	11.42	9.89	0.29
Cash & Cash Equivalents	6.45	27.61	11.42	9.89	0.29
Cash Growth	-76.63%	141.71%	15.45%	3261.57%	8.73%
Receivables	0	0	0.05	0.18	0.07
Other Current Assets	1.43	1.33	0.16	0.16	0.08
Total Current Assets	7.89	28.94	11.63	10.24	0.45
Property, Plant & Equipment	0.21	0.23	0.16	0.15	0.01
Other Long-Term Assets	1.19	2.17	0.01	0.01	0.01
Total Long-Term Assets	1.4	2.41	0.17	0.16	0.02
Total Assets	9.28	31.35	11.8	10.39	0.47
Accounts Payable	2.8	1.75	2.06	0.27	0.15
Current Debt	0	0	0	0.18	0.01
Other Current Liabilities	0.72	3	3.38	0.36	1.85
Total Current Liabilities	3.52	4.75	5.44	0.81	2.02
Long-Term Debt	0	0	0	0.01	0.03
Other Long-Term Liabilities	0	0	2	0	0
Total Long-Term Liabilities	0	0	2	0.01	0.03
Total Liabilities	3.52	4.75	7.44	0.83	2.04
Total Debt	0	0	0	0.2	0.04
Debt Growth	-	-	-	398.36%	-86.75%
Retained Earnings	-104.36	-78.4	-64.38	-45.81	-42.85
Shareholders' Equity	5.76	26.6	4.36	9.57	-1.57
Net Cash / Debt	6.45	27.61	11.42	9.7	0.25
Net Cash / Debt Growth	-76.63%	141.71%	17.81%	3708.50%	-
Net Cash Per Share	3.55	24.40	28.09	105.11	1260.44
Working Capital	4.37	24.19	6.19	9.42	-1.57
Book Value Per Share	3.17	23.51	10.73	103.72	-7789.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).